|
|
|||||||
|
|
|
|
|
|
|
|
|
|||||||
|
BASE DE DONNÉES-RECHERCHE | |
GROUPE DE RECHERCHE CLINIQUE ORIENTEE PATIENTS | ||||
|
|||||||
|
Jean-Michel AUBRY | CV du Chef de Groupe | Sujet de Recherche | Composition du Groupe | |||
|
|
|
|
|
Coordonnées du groupe
Dr. J.-M. AUBRY HUG/ Dpt Psychiatrie Consultation Jonction Bd St Georges 16-18 1205 Genève Jean-Michel.Aubry@hcuge.ch Tél.: + 41 22 327 75 65 Fax: + 41 22 327 75 99 Commentaires Pages générées le 17.11.2015 |
Sujet de recherche
|
Publications du groupe
|
Domaines de recherche
Groupe de recherches sur les Thérapeutiques des Troubles de l'Humeur et Anxieux
Plusieurs projets de recherche sont en cours dans le cadre d'un groupe de recherche clinique de la Clinique de Psychiatrie Adulte (GRETTHA - Groupe de recherches sur les Thérapeutiques des Troubles
de l'Humeur et Anxieux). Ce groupe est co-dirigé avec les Drs G. Bondolfi et J.-M. Aubry et bénéficie des contributions d'un réseau de jeunes médecins et psychologues cliniciens de la clinique.
Toujours sur le principe du réseau, il tisse progressivement des liens avec des groupes de chercheurs en sciences de base (pharmacocinétique, neurobiologie, génétique).
Au sein des recherches du groupe GRETTHA, l'implication de l'intéressé concerne plus particulièrement l'évaluation et le traitement des troubles bipolaires et notamment la prévention des rechutes. Publications du groupe Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder. CNS DRUGS : THE CLINICAL REVIEW JOURNAL OF DRUGS AND THERAPEUTICS IN PSYCHIATRY AND NEUROLOGY 2009 vol. 23(3) pp. 225-240 GRANDJEAN EM, AUBRY JM Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. CNS DRUGS : THE CLINICAL REVIEW JOURNAL OF DRUGS AND THERAPEUTICS IN PSYCHIATRY AND NEUROLOGY 2009 vol. 23(4) pp. 331-349 GRANDJEAN E, AUBRY JM Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS DRUGS : THE CLINICAL REVIEW JOURNAL OF DRUGS AND THERAPEUTICS IN PSYCHIATRY AND NEUROLOGY 2009 vol. 23(5) pp. 397-418 GRANDJEAN E, AUBRY JM Performance of the Mood Disorder Questionnaire (MDQ) according to bipolar subtype and symptom severity. EUROPEAN PSYCHIATRY : THE JOURNAL OF THE ASSOCIATION OF EUROPEAN PSYCHIATRISTS 2009 vol. 24(5) pp. 341-344 GERVASONI N, WEBER ROUGET B, MIGUEZ M, DUBUIS V, BIZZINI V, GEX-FABRY M, BONDOLFI G, AUBRY JM [Screening for bipolar disorders: a review of the literature]. L'ENCEPHALE 2009 vol. 35(6) pp. 570-576 WEBER ROUGET B, AUBRY JM Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression? PHARMACOLOGICAL REVIEWS 2009 vol. 59(3) pp. 202-206 GERVASONI N, AUBRY JM, GEX-FABRY M, BERTSCHY G, BONDOLFI G Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 2009 vol. 33(6) pp. 1017-1021 TRINGALI G, LISI L, DE SIMONE ML, AUBRY JM, PREZIOSI P, POZZOLI G, NAVARRA P Early effects of mood stabilizers on the Akt/GSK-3 beta signaling pathway and on cell survival and proliferation PSYCHOPHARMACOLOGY 2009 vol. 205(3) pp. 419-429 AUBRY JM, SCHWALD M, BALLMANN E, KAREGE F Frequency of dysphoria and mixed states. PSYCHOPATHOLOGY 2008 vol. 41(3) pp. 187-193 BERTSCHY G, GERVASONI N, FAVRE S, LIBEREK C, RAGAMA PARDOS EMNA, AUBRY JM, GEX-FABRY M, DAYER A CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response. THERAPEUTIC DRUG MONITORING 2008 vol. 30(4) pp. 474-482 GEX-FABRY M, EAP CB, ONEDA B, GERVASONI N, AUBRY JM, BONDOLFI G, BERTSCHY G Phenomenology of mixed states: a principal component analysis study BIPOLAR DISORDERS 2007 vol. 9 pp. 907-912 BERTSCHY, G, GERVASONI, N, FAVRE, S, LIBEREK, C, RAGAMA-PARDOS, E, AUBRY, JM, GEX-FABRY, M, DAYER, A Efficacy of psychoeducational approaches on bipolar disorders: a review of the literature. JOURNAL OF AFFECTIVE DISORDERS 2007 vol. 98(1-2) pp. 11-27 ROUGET BW, AUBRY JM The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients JOURNAL OF PSYCHIATRIC RESEARCH 2007 vol. 41 pp. 290-294 AUBRY JM, GERVASONI N, OSIEK C, PERRET G, ROSSIER MF, BERTSCHY G, BONDOLFI G Time course of response to paroxetine: Influence of plasma level PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 2007 vol. 31 pp. 892-900 GEX-FABRY M, GERVASONI N, EAP CB, AUBRY JM, BONDOLFI G, BERTSCHY G Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression PSYCHONEUROENDOCRINOLOGY 2007 vol. 32(5) pp. 575-579 STEIMER T, PYTHON A, SCHULZ PE, AUBRY JM No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects BIOLOGICAL PSYCHIATRY 2006 vol. 60 pp. 202-203 DELORME R, DURAND CM, BETANCUR C, WAGNER M, RUHRMANN S, GRABE HJ, NYGREN G, GILLBERG C, LEBOYER M, BOURGERON T, COURTET P, JOLLANT F, BURESI C, AUBRY JM, BAUD P, BONDOLFI G, BERTSCHY G Impact of the life goals group therapy program for bipolar patients: an open study JOURNAL OF AFFECTIVE DISORDERS 2006 vol. 93(1-3) pp. 253-257 DENIS DE ANDRES RACHEL, AILLON NANCY, BARDIOT MARIE-CLAUDE, BOURGEOIS PATRICK, MERTEL STEFAN, NERFIN FREDERIC, ROMAILLER GLADYS, GEX-FABRY MARIANNE, AUBRY JEAN-MICHEL Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic states NORDIC JOURNAL OF PSYCHIATRY 2006 vol. 60 pp. 181-182 BECH P, GEX-FABRY M, AUBRY JM, FAVRE S, BERTSCHY G Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus PSYCHOPHARMACOLOGY 2006 vol. 188(3) pp. 386-392 TRINGALI GIUSEPPE, AUBRY JEAN-MICHEL, NAVARRA PIERLUIGI, POZZOLI GIACOMO A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study SWISS MEDICAL WEEKLY 2006 vol. 136 pp. 78-85 BONDOLFI G, AUBRY JM, GOLAZ J, GEX-FABRY M, GERVASONI N, BERTSCHY G Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association THERAPIE 2006 vol. 61(6) pp. 531-533 LIBEREK KRZYSZTOF, AUBRY JEAN-MICHEL, BAUD PATRICK Efficacy and safety of olanzapine plus valproate in the treatment of acute mania: an open study INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 2003 vol. 7 pp. 131-134 AUBRY JM, RAGAMA-PARDOS E, FAVRE S, M MENZINGER, MUSCIONICO M, SANCHEZ S, GEX-FABRY M, FERRERO F, BERTSCHY G Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism PHARMACOGENOMICS 2003 vol. 3 pp. 101-104 ROUSSEVAL A, HENRY C., VAN DEN BULKE D., FOURNIER G., LAPLANCHE J.L., LEBOYER M., BELLIVIER F., AUBRY JEAN-MICHEL, BAUD P., BOUCHERIE M., BURESI C., FERRERO F, MALAFOSSE A. Decreased serum brain-derived neurotrophic factor levels in major depressed patients PSYCHIATRY RESEARCH 2002 vol. 109 pp. 143-148 KAREGE F, PERRET G, BONDOLFI G, SCHWALD M, BERTSCHY G, AUBRY JM A theoretical reappraisal of mixed states: dysphoria as a third dimension BIPOLAR DISORDERS 2000 vol. 2 pp. 316-324 DAYER A, AUBRY JM, ROTH L, DUCRET S, BERTSCHY G Mania and hypomania induced by olanzapine or risperidone : a critical review of reported cases THE JOURNAL OF CLINICAL PSYCHIATRY 2000 vol. 61 pp. 649-655 AUBRY JEAN-MICHEL, SIMON AE, BERTSCHY GILLES Domaines de recherche |